-
Pharma and CRO Spatial Summit Series 152 min
-
Feedback Survey 1 min
Pharma and CRO Spatial Summit Series
Learn how 6 of our Pharma and Contract Research Organizations (CROs) customers are designing and executing GeoMx® DSP experiments for clinical studies.
Summit Overview
Join us virtually, for our 2nd Pharma and CRO spatial biology event. Hear how Pharma and Contract Research Organizations (CROs) are designing and executing GeoMx experiments for clinical studies. Learn about analysis of spatial biology data.
Session Highlights:
- GeoMx execution for large scale biomarker discovery clinical studies
- Spatial bioinformatics tools pushing the frontiers of spatial biology
Program Agenda
| Welcome and Opening Remarks | Leslie Abad Assoc. Director Global Pharma and CRO Market Development, NanoString |
| Expanding the Limits and Scope of GeoMx DSP for Use in Larger Clinical Cohorts and Study Designs | Joshua Rusbuldt, MA Scientist of R&D Janssen Pharmaceuticals |
| Presentation from GlaxoSmithKline | David Krull, MS Associate Director and GSK Fellow in Cellular Biomarkers and Edward Bonnevie, PhD Investigator in Clinical Histotechnology GlaxoSmithKline |
| Fusing Pathology & Omics in the Pursuit of Spatial Biology Discovery | Jessica Runyon, MS Director of Product Management for CRO Services Canopy Biosciences |
| How to Leverage spatial omics from discovery to drug development | Corinne Ramos, PhD Director of Marketing and Innovation, ImaBiotech |
| GeoMx® NHG Pipeline on BaseSpace Sequence Hub? | Ana Sanchez Product Manager, Lab Solutions Software Illumina |
| GeoMx® Journey from Data and Answer | Jason Reeves, PhD Associate Director, Computational Biology NanoString Technologies |
| Q&A | Moderated by Espy Anguiano, PhD Scientific Market Development Director– BioPharma NanoString Technologies |
For Research Use Only. Not for Use in Diagnostic Procedures.